Gruseke Christopher R 4
4 · Bankwell Financial Group, Inc. · Filed Feb 11, 2026
Research Summary
AI-generated summary of this filing
Bankwell (BWFG) CEO Christopher Gruseke Sells 5,056 Shares, Receives Awards
What Happened
- Christopher R. Gruseke, CEO of Bankwell Financial Group (BWFG), reported three transactions on 2026-02-09: two awards (total 9,170 shares) and the disposition of 5,056 shares for about $251,738. The sale proceeds were roughly $49.79 per share (reported price range $49.38–$50.27).
- The awards consist of a 7,654-share grant under the 2022 Stock Plan (mix of restricted and performance-restricted stock) and 1,516 shares that were granted and vested on 2026-02-09 (related to 2023–2024 additional performance shares). The 5,056 shares were withheld/sold through the company’s cashless stock exercise/withholding program to cover tax withholding tied to vesting.
Key Details
- Transaction date: 2026-02-09; Form filed: 2026-02-11 (appears timely).
- Sale: 5,056 shares disposed at reported price ~$49.79 (range $49.38–$50.27) for about $251,738.
- Awards: 7,654 shares granted (3,827 restricted — vest in three equal annual installments beginning 2/7/2027; 3,827 performance restricted with a three-year cliff vesting 2/7/2029 if goals met). Plus 1,516 shares granted and vested immediately on 2/9/2026.
- Tax withholding: 5,056 shares were withheld/sold to cover tax liability for vesting (footnote states this covered taxes on a total of 11,265 shares).
- Shares reported owned: 62,287 shares reported as owned jointly with spouse on the Form 4.
Context
- This was not an opportunistic open-market sale but a company-sponsored cashless withholding/sale to satisfy taxes on vested awards — a routine administrative transaction that is common when equity grants vest.
- The awards include both time-based restricted stock and performance-based shares that may vest only if targets are met; performance shares have multi-year vesting cliffs (2029 for the 3-year performance tranche).
Insider Transaction Report
Form 4
Transactions
- Award
Common Stock
[F1]2026-02-09+7,654→ 7,654 total - Award
Common Stock
[F2]2026-02-09+1,516→ 177,203 total - Sale
Common Stock
[F3][F4][F5]2026-02-09$49.79/sh−5,056$251,738→ 172,147 total
Holdings
- 4,568
Common Stock
[F6] - 22,500
Common Stock
[F7] - 12,500(indirect: By IRA)
Common Stock
Footnotes (7)
- [F1]7,654 shares of Bankwell Financial Group, Inc. stock granted pursuant to the 2022 Bankwell Financial Group, Inc. Stock Plan. 3,827 of those shares are restricted stock that will vest in three substantially equal annual installments, with the first installment to vest on February 7, 2027 and the second and third installments to vest on each annual anniversary of the vesting date thereafter. 3,827 of those shares are performance restricted stock with a three year cliff vesting on February 7, 2029 if the performance goal is achieved.
- [F2]1,516 shares were granted and vested on February 9, 2026. These shares were related to 2023 and 2024 additional performance shares.
- [F3]Range of reported sale price is $49.38 - $50.27. Reporting person agrees to provide individual transaction information to SEC upon request.
- [F4]62,287 shares reported are owned jointly with spouse.
- [F5]5,056 shares were withheld and sold through the Company sponsored cashless stock exercise program, to cover the tax liability for vesting a total of 11,265 shares.
- [F6]13,704 shares of Bankwell Financial Group, Inc. stock granted pursuant to the 2022 Bankwell Financial Group, Inc. Stock Plan. 6,852 of those shares are restricted stock that will vest in three substantially equal annual installments, with the first installment to vest on February 7, 2025 and the second and third installments to vest on each annual anniversary of the vesting date thereafter. 6,852 of those shares are performance restricted stock and may vest when and if the performance goal is achieved.
- [F7]22,500 shares of Bankwell Financial Group, Inc. stock granted pursuant to the 2022 Bankwell Financial Group, Inc. Stock Plan. These shares are performance restricted stock with a three year cliff vesting on February 7, 2028 if the performance goals are achieved.
Signature
/s/ Angelo G. Fusaro, Attorney-in-Fact for Christopher R. Gruseke|2026-02-11